Evaluation of flavonols and derivatives as human cathepsin B inhibitor

Natural Product Research

Volumn 29, Issue 23, 2015, Pages 2212-2214

  Ramalho, Suelem D ^a   De Sousa, Lorena R F ^a   Burger, Marcela C M ^a   Lima, Maria Inês S ^a   Da Silva, M Fátima Das G F ^a   Fernandes, João B ^a   Vieira, Paulo C ^a  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

cathepsin B; flavonoids; uncompetitive inhibitor

Indexed keywords

AGLYCONE; CATHEPSIN B; CATHEPSIN B INHIBITOR; FLAVONOL DERIVATIVE; MYRICETIN; PLANT EXTRACT; QUERCETIN; FLAVONOID;

ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; ENZYME INHIBITION; FRACTIONATION; IC50; MEDICINAL PLANT; MYRCIA LINGUA; SCRUB; SOLVENT EXTRACTION; ANTAGONISTS AND INHIBITORS; CHEMISTRY; HUMAN; MYRICA;

CATHEPSIN B; FLAVONOIDS; FLAVONOLS; HUMANS; INHIBITORY CONCENTRATION 50; MYRICA; PLANT EXTRACTS; QUERCETIN;

EID: 84942367261     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2014.1002404     Document Type: Article

References (12)

1. Bisswanger H. 2008. Enzyme kinetics: principles and methods. 2nd ed. Weinheim: Wiley.
2. Copeland RA. 2005. Evaluation of enzyme inhibitors in drug discovery: a guide for medicinal chemists and pharmacologists. 2nd ed. New Jersey: Wiley.
3. Cragg GM, Grothaus PG, Newman DJ. 2009. Impact of natural products on developing new anti-cancer agents. Chem Rev. 109:3012-3043.
4. de Vries J, Janseen P, Hollman P, Staveren W, Katan M. 1997. Consumption of quercetin and kaempferol in free living subjects eating a variety of diets. Cancer Lett. 114:141-144.
5. Harborne JB, Williams C. 2000. Advances in flavonoid research since 1992. Phytochemistry. 55:481-504.
6. Havsteen BH. 2002. The biochemistry and medical significance of flavonoids. Pharmacol Ther. 96:66-202.
7. Nenaah G. 2014. Toxic and antifeedant activities of prenylated flavonoids isolated from Tephrosia apollinea L. against three major coleopteran pests of stored grains with reference to their structure-activity relationship. Nat Prod Res. 28:2245-2252.
8. Pinheiro MHO, Monteiro R. 2010. Contribution to the discussions on the origin of the cerrado biome: brazilian savanna. Braz J Biol. 70:95-102.
9. Skrzydlewska E, Sulkowska M, Wincewicz A, Koda M, Sulkowski S. 2005. Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer. World J Gastroenterol. 11:4225-4229.
10. Tomoo K. 2010. Development of cathepsin inhibitors and structure-based design of cathepsin B-Specific Inhibitor. Curr Top Med Chem. 10:696-707.
11. WHO: World Health Organization. [Internet]. [cited 2014 June 15]. Available from: http://www.who.int/features/qa/15/en/index.html
12. Withana NP, Blum G, Sameni M, Slaney C, Anbalagan A, Olive MB, Bidwell BN, Edgington L, Wang L, Moin K, et al. 2012. Cathepsin B inhibition limits bone metastasis in breast cancer. Cancer Res. 72:1199-1209.